Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1981 7
1982 6
1983 3
1984 7
1985 6
1986 6
1987 6
1988 11
1989 17
1990 25
1991 29
1992 27
1993 37
1994 54
1995 47
1996 50
1997 50
1998 64
1999 73
2000 70
2001 82
2002 106
2003 97
2004 133
2005 139
2006 222
2007 208
2008 262
2009 316
2010 343
2011 211
2012 231
2013 273
2014 244
2015 289
2016 282
2017 271
2018 300
2019 343
2020 250
2021 79
Text availability
Article attribute
Article type
Publication date

Search Results

4,620 results
Results by year
Filters applied: . Clear all
Page 1
How we diagnose and treat iron deficiency anemia.
Auerbach M, Adamson JW. Auerbach M, et al. Am J Hematol. 2016 Jan;91(1):31-8. doi: 10.1002/ajh.24201. Epub 2015 Nov 17. Am J Hematol. 2016. PMID: 26408108 Free article. Review.
Comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia: A randomized trial.
Adkinson NF, Strauss WE, Macdougall IC, Bernard KE, Auerbach M, Kaper RF, Chertow GM, Krop JS. Adkinson NF, et al. Am J Hematol. 2018 May;93(5):683-690. doi: 10.1002/ajh.25060. Epub 2018 Feb 24. Am J Hematol. 2018. PMID: 29417614 Free PMC article. Clinical Trial.
Composite incidences of moderate-to-severe HSRs, including anaphylaxis, or moderate-to-severe hypotension from baseline to week 5 (primary safety end point) were 0.6% and 0.7% in the ferumoxytol and FCM groups, respectively, with ferumoxytol noninferior to FCM. ...I …
Composite incidences of moderate-to-severe HSRs, including anaphylaxis, or moderate-to-severe hypotension from baseline to week 5 (primary s …
Intrinsic peroxidase-like activity of ferromagnetic nanoparticles.
Gao L, Zhuang J, Nie L, Zhang J, Zhang Y, Gu N, Wang T, Feng J, Yang D, Perrett S, Yan X. Gao L, et al. Nat Nanotechnol. 2007 Sep;2(9):577-83. doi: 10.1038/nnano.2007.260. Epub 2007 Aug 26. Nat Nanotechnol. 2007. PMID: 18654371
Nanoparticles containing magnetic materials, such as magnetite (Fe3O4), are particularly useful for imaging and separation techniques. ...Based on this finding, we have developed a novel immunoassay in which antibody-modified magnetite nanoparticles provide three fu …
Nanoparticles containing magnetic materials, such as magnetite (Fe3O4), are particularly useful for imaging and separation techniques …
Ferumoxytol.
[No authors listed] [No authors listed] 2021 Jul 19. Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006–. 2021 Jul 19. Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006–. PMID: 29999820 Free Books & Documents. Review.
No information is available on the use of ferumoxytol during breastfeeding; however, the drug has been given safely to neonates intravenously as a magnetic resonance contrast agent.[1] An alternate intravenous iron product with more published data on breastfeeding availabl …
No information is available on the use of ferumoxytol during breastfeeding; however, the drug has been given safely to neonates intra …
Magnetoreception.
Gould JL. Gould JL. Curr Biol. 2010 May 25;20(10):R431-5. doi: 10.1016/j.cub.2010.03.045. Curr Biol. 2010. PMID: 20504748 Free article.
Magnetic resonance imaging of stem cell-macrophage interactions with ferumoxytol and ferumoxytol-derived nanoparticles.
Nejadnik H, Tseng J, Daldrup-Link H. Nejadnik H, et al. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2019 Jul;11(4):e1552. doi: 10.1002/wnan.1552. Epub 2019 Feb 7. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2019. PMID: 30734542 Free PMC article. Review.
If a host immune response is identified within the first week post-transplant, immune modulating therapies could be applied to prevent graft failure and support engraftment. Ferumoxytol (Feraheme) is an FDA approved iron oxide nanoparticle preparation for the treatm …
If a host immune response is identified within the first week post-transplant, immune modulating therapies could be applied to prevent graft …
Brain iron deposition after Ferumoxytol-enhanced MRI: A study of Porcine Brains.
Theruvath AJ, Aghighi M, Iv M, Nejadnik H, Lavezo J, Pisani LJ, Daldrup-Link HE. Theruvath AJ, et al. Nanotheranostics. 2020 Jun 18;4(4):195-200. doi: 10.7150/ntno.46356. eCollection 2020. Nanotheranostics. 2020. PMID: 32637297 Free PMC article.
However, long-term follow up studies of the brain after intravenous iron oxide administration have not been reported thus far. In this study, we investigated, if intravenously administered ferumoxytol nanoparticles are deposited in porcine brains. ...We suggest iron …
However, long-term follow up studies of the brain after intravenous iron oxide administration have not been reported thus far. In thi …
Ferumoxytol Does Not Impact Standardized Uptake Values on PET/MR Scans.
Muehe AM, Yerneni K, Theruvath AJ, Thakor AS, Pribnow A, Avedian R, Steffner R, Rosenberg J, Hawk KE, Daldrup-Link HE. Muehe AM, et al. Mol Imaging Biol. 2020 Jun;22(3):722-729. doi: 10.1007/s11307-019-01409-3. Mol Imaging Biol. 2020. PMID: 31325083 Free PMC article.
However, it is not known if the strong T1- and T2-contrast obtained with iron oxide nanoparticles such as ferumoxytol could affect MR-based attenuation correction of PET data. ...This is important, because it allows injection of ferumoxytol contrast prior to …
However, it is not known if the strong T1- and T2-contrast obtained with iron oxide nanoparticles such as ferumoxytol could af …
4,620 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page